French trial tests reintroducing chemotherapy after liver metastasis resection

▸ TREATMENT

The IRIMAD phase III trial is randomizing patients who responded well to preoperative FOLFIRI and underwent curative resection of metachronous colorectal liver metastases to postoperative FOLFIRI reintroduction in the experimental arm. (Dig Liver Dis)